Molecular Cell APC and Open Access: Current Price, Hybrid Reality, and When the Fee Is Actually Worth It
Molecular Cell lists a USD 10,400 APC for optional open access. Here is what that price means in practice.
Next step
Choose the next useful decision step first.
Use the guide or checklist that matches this page's intent before you ask for a manuscript-level diagnostic.
Molecular Cell publishing costs and open access options
APC is one cost. Funder mandates, institutional agreements, and access route timing all shape what you actually pay.
What shapes what you pay
- Gold OA at Molecular Cell costs $10,400 USD. Check whether your institution has a read-and-publish agreement that waives this.
- Funder mandates (NIH, Wellcome, UKRI) may require immediate OA — verify compliance before choosing a subscription route.
- Accepted authors typically have 48-72 hours to choose their access route before proofs begin.
When OA is worth the cost
- When your funder or institution requires it — non-compliance can affect future funding.
- When your topic benefits from broad immediate access beyond institutional subscribers.
- Molecular Cell's IF 16.6 means OA papers here have real citation upside.
Quick answer: The current Molecular Cell APC shown on the ScienceDirect journal page is USD 10,400 excluding taxes for optional open access. Molecular Cell remains a hybrid journal, so the key decision is not "what does publication cost?" but whether you need to pay for open access at all. The subscription route is still free, and the official page says the amount may be reduced during submission if applicable.
The Molecular Cell journal page is the best cluster reference if you want to compare APC, impact factor, acceptance rate, and review-time context in one place.
Molecular Cell APC at a glance
Item | Current position |
|---|---|
Gold open-access APC | USD 10,400 excluding taxes |
Subscription publication | No publication fee charged to authors |
Journal model | Hybrid |
Pricing flexibility | The amount may be reduced during submission if applicable |
CiteScore | 24.4 |
Impact Factor | 16.6 |
Submission to acceptance | 151 days |
That is enough to frame the real decision. The question is not whether Molecular Cell is expensive. It is. The useful question is whether paying for immediate OA changes the value of the target enough to justify the cost.
Current metrics that matter alongside the APC
Metric | Current figure |
|---|---|
JIF (2024) | 16.6 |
CiteScore | 24.4 |
Submission to acceptance | 151 days |
Editorial identity | Mechanistic molecular biology with broad consequence |
At this tier, price only matters after fit. Molecular Cell is expensive because it sits in a high-selectivity Cell Press lane. If the paper is not already credible for the journal, the APC conversation is premature.
Longer-term trend context
Year | Impact factor |
|---|---|
2017 | 14.7 |
2018 | 14.5 |
2019 | 15.6 |
2020 | 16.7 |
2021 | 19.3 |
2022 | 17.4 |
2023 | 16.6 |
2024 | 16.6 |
The current figure stayed at 16.6 compared to the previous year, which is useful. It means authors should treat Molecular Cell as a stable elite specialty venue rather than a journal currently gaining or losing citation ground fast.
What the APC question actually means here
Molecular Cell is not a journal where most authors should start with price.
- If the manuscript is a weak fit, $0 on the subscription route is still a bad submission decision.
- If the manuscript is a strong fit and a funder or institution covers OA, the APC may be operationally easy.
- If the manuscript is strong but the OA money would come from personal or unplanned lab funds, the subscription route often solves the problem.
That is the key hybrid-journal distinction. The APC is optional. The fit decision is not.
Agreement coverage, discounts, and what the official source actually says
The official ScienceDirect page makes one careful statement: the amount you pay may be reduced during submission if applicable.
That is the right level of certainty for this page too.
- it means some authors will see a reduced bill
- it does not guarantee your institution covers Cell Press titles
- it does not mean you should assume standard Elsevier coverage automatically applies
The practical move is to check with your library or grants office before acceptance, not after.
Readiness check
Run the scan while the topic is in front of you.
See score, top issues, and journal-fit signals before you submit.
How Molecular Cell compares with nearby alternatives
Journal | OA price signal | Impact signal | Practical read |
|---|---|---|---|
Molecular Cell | USD 10,400 hybrid OA option | JIF 16.6, CiteScore 24.4 | Deep mechanistic molecular biology |
Neuron | USD 10,400 hybrid OA option | JIF 15.3, CiteScore 22.1 | Equivalent Cell Press price, different audience |
Cell Metabolism | USD 10,400 hybrid OA option | JIF 30.9, CiteScore 45.5 | Same Cell Press APC, stronger metabolism-specific citation tier |
Cell Reports | USD 5,620 fully OA | JIF 6.9, CiteScore 12.9 | Lower-cost Cell Press entry lane |
That table makes the real comparison obvious. Molecular Cell is priced like the other premium Cell Press hybrid titles, not like Cell Reports. So the APC only makes sense when the manuscript genuinely belongs in this upper tier.
What we see in pre-submission review work
In pre-submission review work, Molecular Cell APC questions usually hide a fit problem.
The paper is still descriptive rather than mechanistic. Molecular Cell explicitly says it wants papers that answer longstanding questions, open new avenues, or change how we think about biological processes. If the mechanism is incomplete, the APC is the least important issue in the room.
The lab is budgeting for prestige rather than audience. We see authors treat the APC like a badge purchase. That is the wrong frame. If the story would perform just as well in a cheaper or more natural venue, the premium spend is hard to defend.
Funding gets checked too late. The journal page leaves room for reduced pricing during submission, but that only helps authors who check coverage early. Waiting until acceptance creates avoidable operational friction.
Submit if / Think twice if
Submit to Molecular Cell and think seriously about the APC if:
- the paper resolves a real molecular mechanism with depth
- the journal's specific audience changes the paper's reach
- open access is required or well funded
- the funding path is already clear
Think twice if:
- the story is still partial, descriptive, or short on orthogonal evidence
- you are using the APC question to avoid a harder fit decision
- a cheaper or more focused venue would preserve most of the value
- the subscription route already satisfies the real publication need
Practical verdict
For 2026, the clean read is:
- listed APC: USD 10,400 excluding taxes
- subscription route: free
- pricing flexibility: possible, but contextual
- true decision variable: fit first, APC second
If the manuscript already looks like a real Molecular Cell paper, the APC can be justified when immediate OA is required or covered. If the fit is borderline, the more expensive mistake is the wrong journal choice, not the invoice.
Before you submit, a Molecular Cell submission readiness check can pressure-test whether the story has the mechanistic depth this journal actually expects.
Frequently asked questions
The current ScienceDirect journal page lists Molecular Cell's optional open-access APC as USD 10,400 excluding taxes.
Yes. Molecular Cell is hybrid. The subscription route remains available with no publication fee charged to authors.
Possibly, but the official journal page only states that the amount may be reduced during submission if applicable. Authors should check institutional or funder coverage case by case rather than assuming Cell Press titles are included.
Molecular Cell currently reports a 2024 impact factor of 16.6, a CiteScore of 24.4, and about 151 days from submission to acceptance on the current journal insights page.
The APC is easiest to justify when the manuscript already looks like a true Molecular Cell paper, immediate open access is required or funded, and the journal's audience materially changes the paper's reach.
Sources
Before you upload
Want the full picture on Molecular Cell?
Scope, selectivity, what editors want, common rejection reasons, and submission context, all in one place.
These pages attract evaluation intent more than upload-ready intent.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Start here
Same journal, next question
- Molecular Cell Submission Guide
- Is Molecular Cell a Good Journal? Impact, Scope, and Fit
- Molecular Cell Impact Factor 2026: 16.6, Q1, Rank 7/319
- Molecular Cell Acceptance Rate: What Authors Can Use
- Molecular Cell Pre Submission Checklist: 12 Items Editors Verify Before Peer Review
- How to Avoid Desk Rejection at Molecular Cell
Supporting reads
Want the full picture on Molecular Cell?
These pages attract evaluation intent more than upload-ready intent.